Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 6/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.37 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 4/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | PRSS12 | P56730 | 3/20 | 0.33 |
| ▸ | MTTP | P55157 | 3/20 | 0.32 |
| ▸ | PLK3 | Q9H4B4 | 2/20 | 0.32 |
| ▸ | HSPH1 | Q92598 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.31 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL404114 | 0.93 | PLK1 (0.41) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL402944 | 0.90 | NTRK1 (0.39) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL6091314 | 0.89 | NTRK1 (0.41) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL404113 | 0.89 | NTRK1 (0.41) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL403620 | 0.86 | NTRK1 (0.41) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL401283 | 0.86 | NTRK1 (0.40) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL5318000 | 0.85 | NTRK1 (0.43) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL401065 | 0.84 | NTRK1 (0.39) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL402751 | 0.84 | NTRK1 (0.40) | PLK1NTRK1NTRK2PPARAPPARG | |
| SCHEMBL401877 | 0.84 | NTRK1 (0.39) | PLK1NTRK1NTRK2PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060089392-A1 | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2006-04-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089392-A1 | Ester derivatives and medicinal use thereof | MTTP, CETP, LIPA | PLK1 4544/4885NTRK1 3420/4885NTRK2 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.